Fluorescent nucleotide analogs and uses therefor
Labeled nucleotide analogs used in place of naturally occurring nucleoside triphosphates or other analogs in template directed nucleic acid synthesis reactions and other nucleic acid reactions, and various analyses based thereon, including DNA sequencing, single base identification, hybridization assays and others.
1. A composition, comprising a labeled nucleotide analog, comprising the formula:
wherein B is a natural or non-natural nucleobase;
S is selected from a sugar moiety, an acyclic moiety and a carbocyclic moiety;
L is a detectable label;
R 1 is selected from O and S;
R 2 , R 3 and R 4 are independently selected from O, NH, S, methylene, substituted methylene, C(O), C(CH 2 ), CH 2 CH 2 , C(OH)CH 2 R where R is 4-pyridine or 1-imidazole, provided that R 4 is additionally selected from
R 5 , R 6 , R 7 , R 8 , R 11 and R 13 are independently selected from O, BH 3 , and S; and
R 9 , R 10 and R 12 are independently selected from O, NH, S, methylene, substituted methylene, C(O), C(CH 2 ), CH 2 CH 2 , C(OH)CH 2 R where R is 4-pyridine or 1-imidazole;
provided that at least one of R 2 , R 3 and R 4 is not O, and provided further that if R 2 and R 3 are O, and R 4 is, selected from
than at least one of R 9 , and R 10 , is not O.
2. The composition of claim 1 , wherein at least one of R 2 , R 3 is not O.
3. The composition of claim 1 , wherein R 4 comprises:
and wherein at least one of R 2 , R 3 , R 9 and R 10 is selected from O, NH, S, methylene, substituted methylene, C(O), C(CH 2 ), CH 2 CH 2 , C(OH)CH 2 R where R is 4-pyridine or 1-imidazole; and
R 11 is selected from O, BH 3 and S.
4. The composition of claim 3 , wherein at least one of R 2 , R 3 , R 9 and R 10 is not O.
5. The composition of claim 1 , wherein 4 is
wherein at least one of R 2 , R 3 , R 9 , R 10 and R 12 is selected from NH, S, methylene, substituted methylene, C(O), C(CH 2 ), CH 2 CH 2 , C(OH)CH 2 R where R is 4-pyridine or 1-imidazole, and R 11 and R 13 are independently selected from O, BH 3 and S.
6. The composition of claim 5 , wherein at least one of R 2 , R 3 , R 9 , R 10 and R 12 is not O.
7. The composition of claim 1 , wherein at least one of R 2 , R 3 and R 4 is CR′R″, where R′ and R″ are independently selected from H, F, Cl, OH, NH 2 , alkyl, aminoalkyl, alkenyl, alkynyl, aryl, and heterocycle.
8. A composition, comprising a labeled nucleotide analog, comprising the formula:
wherein B is a natural or non-natural nucleobase;
S is selected from a sugar moiety, an acyclic moiety and a carbocyclic moiety;
L is a detectable label;
R 1 is selected from O and S;
R 2 , R 3 and R 4 are independently selected from O, NH, S, methylene, substituted methylene, C(O), C(CH 2 ), CH 2 CH 2 , C(OH)CH 2 R where R is 4-pyridine or 1-imidazole, provided that R 4 is additionally selected from
R 5 , R 6 , R 7 , R 8 , R 11 and R13 are independently selected from O, BH 3 , and S; and
R 9 , R 10 and R 12 are independently selected from O, NH, S, methylene, substituted methylene, C(O), C(CH 2 ), CH 2 CH 2 , C(OH)CH 2 R where R is 4-pyridine or 1-imidazole; provided that if R 2 and R 3 are O, and R 4 is O, PO 3 or (PO 3 ) 2 , then at least one of R 5 , R 6 and R 7 is not O, and wherein at least one of R 2 , R 3 and R 4 is selected from C(OH)(CH 3 ), and C(NH 2 )[(CH 2 ) 6 CH 3 ]), CH(NHR′″) where R′″ is H, alkyl, alkenyl, alkynyl, aryl, or heterocycle, C(OH)[(CH 2 ) n NH 2 ] where n is 2 or 3, and C(OH)CH 2 R where R is 4-pyridine or 1-imidazole.
9. The composition of claim 1 , wherein R 1 is O, at least one of R 2 and R 3 is CH 2 , at least one of R 2 and R 3 is O, and R 4 is selected from O and NH.
10. The composition of claim 9 , wherein R 5 is BH 3 .
11. The composition of claim 1 , wherein R 1 , R 2 , R 3 , R 4 , R 6 , R 7 and R 8 are O, and R 5 is BH 3 .
12. The composition of claim 3 , wherein R 1 , R 5 , R 6 , R 7 , R 8 , R 9 , R 11 are O, and at least one of R 2 and R 3 is CH 2 and R 10 is selected from NH and O.
13. The composition of claim 1 , wherein B is selected from adenine, guanine, cytidine, thymine, uracil, and inosine.
14. The composition of claim 1 , wherein S is selected from D-ribosyl, D-deoxyribosyl and D-dideoxyribosyl.
15. The composition of claim 1 , wherein L comprises a fluorescent label.
16. The composition of claim 1 , wherein L comprises at least one component of an energy transfer dye complex.
17. A method of determining an identity and relative position of a nucleotide in a template nucleic acid sequence, comprising:
providing the template nucleic acid sequence complexed with a polymerase enzyme capable of template dependent synthesis of a complementary nascent sequence, in a first complex;
contacting the first complex with the compound of claim 1 , wherein the compound is complementary to a known nucleotide; and
detecting whether the compound is incorporated into the nascent strand, incorporation of the compound being indicative that the complementary nucleotide is in a position in the template nucleic acid that is being processed by the polymerase enzyme.
18. A method of determining an identity and relative position of a nucleotide in a template nucleic acid sequence, comprising:
providing the template nucleic acid sequence complexed with a polymerase enzyme capable of template dependent synthesis of a complementary nascent sequence, in a first complex;
contacting the first complex with the compound of claim 1 , wherein the compound is complementary to a known nucleotide, and wherein the contacting step comprises contacting the first complex with a plurality of different compounds each comprising the compound of claim 1 , wherein each different compound comprises a different base selected from A, T, G and C, and an individually detectable label.
19. A kit, comprising at least four differently labeled nucleotide analogs each comprising the structure of the composition of claim 1 , a polymerase enzyme source, and instructions for using the composition with the polymerase enzyme in template directed nucleic acid synthesis.